Cargando…

Serum N-Glycans: A New Diagnostic Biomarker for Light Chain Multiple Myeloma

The aim of this study was to evaluate the diagnostic and differential diagnostic power of serum N-glycans for light chain multiple myeloma (LCMM). A total of 167 cases of subjects, including 42 LCMM, 42 IgG myeloma, 41 IgA myeloma, and 42 healthy controls were recruited in this study. DNA sequencer-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jie, Fang, Meng, Zhao, Yun-Peng, Yi, Chang-Hong, Ji, Jun, Cheng, Cheng, Wang, Meng-Meng, Gu, Xing, Sun, Quan-Sheng, Chen, Xiao-Ling, Gao, Chun-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468189/ https://www.ncbi.nlm.nih.gov/pubmed/26075387 http://dx.doi.org/10.1371/journal.pone.0127022

Ejemplares similares

Serum N‐glycan profiling as a diagnostic biomarker for the identification and assessment of psoriasis
por: Zou, Chengyun, et al.
Publicado: (2021)

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
por: Chen, Jie, et al.
Publicado: (2017)

The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer
por: Liu, Long, et al.
Publicado: (2013)

N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
por: Kodama, Hirotake, et al.
Publicado: (2021)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Light-Chain Multiple Myeloma: A Diagnostic Challenge
por: Silva, Cristina, et al.
Publicado: (2021)

Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3
por: Li, Quan-Fu, et al.
Publicado: (2019)

Site-Specific N-Glycan Characterization of Grass Carp Serum IgM
por: Su, Yi-Ling, et al.
Publicado: (2018)

Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy
por: Hutchison, Colin A, et al.
Publicado: (2012)

Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma
por: Schieferdecker, Aneta, et al.
Publicado: (2020)

Serum Free Light Chain Only Myeloma with Cytoplasmic IgM
por: Ebana, Hideaki, et al.
Publicado: (2014)

Serum free light chains and multiple myeloma: Is it time to extend their application?
por: Markovic, Uros, et al.
Publicado: (2020)

Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
por: Narita, Takuma, et al.
Publicado: (2017)

Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients
por: García de Veas Silva, José Luis, et al.
Publicado: (2016)

Serum IgG N-glycans act as novel serum biomarkers of ankylosing spondylitis
por: Wang, Jingrong, et al.
Publicado: (2019)

IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers
por: Haslund-Gourley, Benjamin S., et al.
Publicado: (2023)

The Association of Serum Neurofilament Light Chain and Acute Ischaemic Stroke Is Influenced by Effective Revascularization
por: Zhou, Fa-Ying, et al.
Publicado: (2022)

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma
por: Yadav, Punit, et al.
Publicado: (2018)

Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers
por: Gebrehiwot, Abrha G., et al.
Publicado: (2018)

Light Chain Myeloma Precipitating Cryoglobulinemic Vasculitis
por: Saeed, Bilal, et al.
Publicado: (2023)

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
por: Hutchison, Colin A, et al.
Publicado: (2008)

Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements
por: Dejoie, Thomas, et al.
Publicado: (2018)

Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study
por: Yadav, Punit, et al.
Publicado: (2020)

INDEPENDENT SYNTHESIS OF LIGHT AND HEAVY CHAINS : Quantitation of Light-Chain Production by Mouse Myeloma Variants
por: Laskov, Reuven, et al.
Publicado: (1974)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Crystalline light chain cast nephropathy in multiple myeloma
por: Lin, Zi-Shan, et al.
Publicado: (2021)

Multiple myeloma with acute light chain cast nephropathy
por: Leung, Nelson, et al.
Publicado: (2023)

Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas
por: Qiao, Xin-Wei, et al.
Publicado: (2014)

Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response to Therapy
por: Moustafa, Muhamad Alhaj, et al.
Publicado: (2015)

Role of serum‐free light chain assay for defining response and progression in immunoglobulin secretory multiple myeloma
por: Tacchetti, Paola, et al.
Publicado: (2022)

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials
por: Lopez-Anglada, Lucia, et al.
Publicado: (2018)

Recent Progress in Chemo-Enzymatic Methods for the Synthesis of N-Glycans
por: Chao, Qiang, et al.
Publicado: (2020)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Identification of serum microRNAs as diagnostic biomarkers for schizophrenia
por: He, Kuanjun, et al.
Publicado: (2019)

Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus
por: Jiang, Jun, et al.
Publicado: (2022)

A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis
por: Wang, Jing-Rong, et al.
Publicado: (2017)

The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China
por: Wang, Hui, et al.
Publicado: (2014)

Discovery of N-glycan Biomarkers for the Canine Osteoarthritis
por: Lee, Hyunjun, et al.
Publicado: (2020)

Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma
por: Ochoa-Rios, Shaaron, et al.
Publicado: (2023)

Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL
por: Chen, Chih-Hao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gn4jao43tb0u4vvui6dpt5039g